Clinical Trials Browser

Interventional × Biopsy, Needle × Thoracic × Clear all

NCT01259089 2019-09-11

Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer

Phase 1/2 Completed

38 enrolled 12 charts

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT00673569 2010-08-09

Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms